GLP-1 Receptor Agonists and Chronic Migraine: A Real-world Cohort Study of Healthcare Utilization and Preventive Escalation (P10-15.017)

Neurology 2026

View at publisher
Authors: Vitória Acar, Mateus Franco, Victor Wang, Hsiangkuo Yuan
DOI: 10.1212/wnl.0000000000215109
Cited by: 1

Abstract

To compare healthcare utilization, triptan use, and preventive-treatment escalation following initiation of a glucagon-like peptide-1 receptor agonist (GLP-1RA) compared with topiramate in adults with chronic migraine (CM).

Fields of Study & Subjects

Migraine and Headache Studies Biochemical effects in animals Parkinson's Disease Mechanisms and Treatments

Publication details

Journal / source
Neurology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
106
Issue
11_Supplement_1
Publication date
9 June 2026
Language
EN